A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation.
Zhen-Xing LiangHua-Shan LiuLi XiongXin YangFeng-Wei WangZi-Wei ZengXiao-Wen HeXian-Rui WuPing LanPublished in: Molecular cancer (2021)
circPLCE1 presents an epigenetic mechanism which disrupts NF-κB nuclear translocation and serves as a novel and promising therapeutic target and prognostic marker.